A detailed history of Aqr Capital Management LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 14,206 shares of TNGX stock, worth $45,885. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,206
Previous 20,651 31.21%
Holding current value
$45,885
Previous $177,000 38.42%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.36 - $11.93 $47,435 - $76,888
-6,445 Reduced 31.21%
14,206 $109,000
Q2 2024

Aug 14, 2024

SELL
$6.66 - $10.15 $201,951 - $307,778
-30,323 Reduced 59.49%
20,651 $177,000
Q1 2024

May 15, 2024

BUY
$7.51 - $12.88 $216,272 - $370,918
28,798 Added 129.86%
50,974 $404,000
Q4 2023

Feb 14, 2024

BUY
$6.52 - $12.01 $144,587 - $266,333
22,176 New
22,176 $219,000
Q3 2022

Nov 14, 2022

BUY
$3.25 - $5.46 $71,597 - $120,283
22,030 New
22,030 $80,000

Others Institutions Holding TNGX

About Tango Therapeutics, Inc.


  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $284M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.